Interestingly, the authors also propose that syntenin levels in breast cancer cells is inversely correlated to estrogen receptor levels and propose that syntenin maintains the growth of breast cancer cells when estrogen-signaling pathway is not available. This evidence concerns the gene ESR1 and breast carcinoma.